Silence Therapeutics plc Depreciation
Silence Therapeutics plc (SLNCF) reported Depreciation of $145.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-10
- Silence Therapeutics plc depreciation for the quarter ending 2026-06-30 was $73.00K, a 9.88% decline year-over-year.
- Silence Therapeutics plc depreciation for the quarter ending 2026-03-31 was $72.00K, a 1.37% decline year-over-year.
- Silence Therapeutics plc depreciation for the quarter ending 2025-12-31 was $77.00K, a 1.32% increase year-over-year.
- Silence Therapeutics plc depreciation for the quarter ending 2025-09-30 was $81.00K, a 5.81% decline year-over-year.
- Silence Therapeutics plc depreciation for fiscal 2025 was $312.00K, a 7.14% decline from fiscal 2024.
- Silence Therapeutics plc depreciation for fiscal 2024 was $336.00K, a 8.94% decline from fiscal 2023.
- Silence Therapeutics plc depreciation for fiscal 2023 was $369.00K, a 2.64% decline from fiscal 2022.
- Silence Therapeutics plc depreciation for fiscal 2022 was $379.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $145.00K 10-Q · filed 2026-08-10 | $222.00K derived: sum of 3 quarters · filed 2026-08-10 | $303.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $72.00K 10-Q · filed 2026-05-07 | $149.00K derived: sum of 2 quarters · filed 2026-05-07 | $230.00K derived: sum of 3 quarters · filed 2026-05-07 | $311.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $158.00K derived: sum of 2 quarters · filed 2026-03-05 | $239.00K derived: sum of 3 quarters · filed 2026-08-10 | $312.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $162.00K derived: sum of 2 quarters · filed 2026-08-10 | $235.00K 10-Q · filed 2025-11-06 | $311.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $154.00K 10-Q · filed 2026-08-10 | $230.00K derived: sum of 3 quarters · filed 2026-08-10 | $316.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $73.00K 10-Q · filed 2026-05-07 | $149.00K derived: sum of 2 quarters · filed 2026-05-07 | $235.00K derived: sum of 3 quarters · filed 2026-05-07 | $321.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $162.00K derived: sum of 2 quarters · filed 2026-03-05 | $248.00K derived: sum of 3 quarters · filed 2026-03-05 | $336.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $172.00K derived: sum of 2 quarters · filed 2025-11-06 | $260.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $174.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $88.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $369.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $379.00K 10-K · filed 2025-02-27 |